SI3924361T1 - Novi derivati triterpena kot zaviralci virusa hiv - Google Patents

Novi derivati triterpena kot zaviralci virusa hiv

Info

Publication number
SI3924361T1
SI3924361T1 SI202030333T SI202030333T SI3924361T1 SI 3924361 T1 SI3924361 T1 SI 3924361T1 SI 202030333 T SI202030333 T SI 202030333T SI 202030333 T SI202030333 T SI 202030333T SI 3924361 T1 SI3924361 T1 SI 3924361T1
Authority
SI
Slovenia
Prior art keywords
hiv inhibitors
triterpene derivatives
novel triterpene
novel
derivatives
Prior art date
Application number
SI202030333T
Other languages
English (en)
Inventor
Parthasaradhi Reddy Bandi
Rathnakar Reddy Kura
Panduranga Reddy Adulla
Bhaskar Reddy Kasireddy
Original Assignee
Hetero Labs Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Labs Limited filed Critical Hetero Labs Limited
Publication of SI3924361T1 publication Critical patent/SI3924361T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SI202030333T 2019-02-11 2020-02-11 Novi derivati triterpena kot zaviralci virusa hiv SI3924361T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201941005217 2019-02-11
PCT/IB2020/051048 WO2020165741A1 (en) 2019-02-11 2020-02-11 Novel triterpene derivatives as hiv inhibitors
EP20720927.1A EP3924361B1 (en) 2019-02-11 2020-02-11 Novel triterpene derivatives as hiv inhibitors

Publications (1)

Publication Number Publication Date
SI3924361T1 true SI3924361T1 (sl) 2024-02-29

Family

ID=70416451

Family Applications (1)

Application Number Title Priority Date Filing Date
SI202030333T SI3924361T1 (sl) 2019-02-11 2020-02-11 Novi derivati triterpena kot zaviralci virusa hiv

Country Status (23)

Country Link
US (1) US20220177439A1 (sl)
EP (2) EP4248960A3 (sl)
JP (1) JP2022520384A (sl)
KR (1) KR20210127955A (sl)
CN (1) CN113727989B (sl)
AU (1) AU2020222299C1 (sl)
BR (1) BR112021015762A2 (sl)
CA (1) CA3129743A1 (sl)
DK (1) DK3924361T3 (sl)
EA (1) EA202192111A1 (sl)
ES (1) ES2965305T3 (sl)
FI (1) FI3924361T3 (sl)
HR (1) HRP20231582T1 (sl)
HU (1) HUE064262T2 (sl)
IL (1) IL285487A (sl)
LT (1) LT3924361T (sl)
MX (1) MX2021009584A (sl)
PL (1) PL3924361T3 (sl)
PT (1) PT3924361T (sl)
RS (1) RS64915B1 (sl)
SI (1) SI3924361T1 (sl)
WO (1) WO2020165741A1 (sl)
ZA (1) ZA202106037B (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115380040A (zh) * 2020-02-11 2022-11-22 熙德隆制药有限公司 作为hiv抑制剂的新型三萜衍生物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152815A (ja) 1982-03-05 1983-09-10 Tamio Nishimura 医療用抗ウイルス剤
WO1995002071A1 (en) 1993-07-09 1995-01-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Selection and use of antiviral peptides
WO1998046238A1 (en) 1997-04-15 1998-10-22 Medichem Research, Inc. Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
HUP9701080A3 (en) 1997-06-23 1999-05-28 Gene Res Lab Inc New York N Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
US6427248B1 (en) 1997-10-09 2002-08-06 David M. Albert Grip-enhancing glove
WO2001007646A2 (de) 1999-07-21 2001-02-01 Martin Heinkelein Verfahren zur quantifizierung der antiviralen wirkung antiviraler wirkstoffe
WO2003037908A1 (en) 2001-10-31 2003-05-08 Ribapharm Inc. Antiviral combination therapy and compositions
US20050014730A1 (en) 2003-04-02 2005-01-20 Carlson Robert M. Anti-fungal formulation of triterpene and essential oil
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
WO2008127364A2 (en) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
AR063546A1 (es) * 2006-11-03 2009-01-28 Panacos Pharmaceuticals Inc DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH.
WO2008138200A1 (en) 2007-05-11 2008-11-20 Hong Kong University Of Science & Technology Nmda and mc receptor antagonists exhibiting neuroprotective and memory enhancing activities
CN101367861A (zh) 2007-08-15 2009-02-18 中国药科大学 2-羟基-3-脱氧五环三萜类化合物及其衍生物、其制备方法及用途
JP2011511812A (ja) 2008-02-14 2011-04-14 バイロケム ファーマ インコーポレイテッド 新規１７βルパン誘導体
US9029414B2 (en) 2008-09-19 2015-05-12 Biotechnology Research Corporation Triterpenoid compounds and methods of use thereof
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
CN102399254A (zh) 2010-09-07 2012-04-04 中国药科大学 新型五环三萜衍生物、其制备方法及用途
CA2826113C (en) 2011-01-31 2018-09-04 Bristol-Myers Squibb Company C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
WO2013020245A1 (en) 2011-08-08 2013-02-14 Glaxosmithkline Llc Carbonyl derivatives of betulin
KR20130028442A (ko) 2011-09-09 2013-03-19 학교법인 한동대학교 항노화 활성을 갖는 베툴린산과 그 유도체 및 이를 함유하는 조성물
KR20140069167A (ko) * 2011-09-21 2014-06-09 브리스톨-마이어스 스큅 컴퍼니 항바이러스 활성을 갖는 신규 베툴린산 유도체
US8906889B2 (en) 2012-02-15 2014-12-09 Bristol-Myers Squibb Company C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
US20150119373A1 (en) 2012-04-24 2015-04-30 Hetero Research Foundation Novel betulinic acid derivatives as hiv inhibitors
US8889854B2 (en) * 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
US9637516B2 (en) 2012-12-31 2017-05-02 Hetero Research Foundation Betulinic acid proline derivatives as HIV inhibitors
EP2953960A1 (en) 2013-02-06 2015-12-16 Bristol-Myers Squibb Company C-19 modified triterpenoids with hiv maturation inhibitory activity
CN105102468A (zh) 2013-02-25 2015-11-25 百时美施贵宝公司 用于治疗hiv的c-3烷基和烯基修饰的桦木酸衍生物
WO2017017630A1 (en) * 2015-07-28 2017-02-02 Hetero Research Foundation Novel betulinic substituted amide derivatives as hiv inhibitors
WO2017149518A1 (en) * 2016-03-04 2017-09-08 Hetero Labs Limited C-3 novel triterpene with c-17 amine derivatives as hiv inhibitors
CN115380040A (zh) * 2020-02-11 2022-11-22 熙德隆制药有限公司 作为hiv抑制剂的新型三萜衍生物

Also Published As

Publication number Publication date
MX2021009584A (es) 2021-09-23
PL3924361T3 (pl) 2024-03-18
CA3129743A1 (en) 2020-08-20
IL285487A (en) 2021-09-30
CN113727989A (zh) 2021-11-30
RS64915B1 (sr) 2023-12-29
EP4248960A2 (en) 2023-09-27
EP4248960A3 (en) 2024-01-03
LT3924361T (lt) 2023-12-27
AU2020222299C1 (en) 2024-05-16
WO2020165741A1 (en) 2020-08-20
JP2022520384A (ja) 2022-03-30
HUE064262T2 (hu) 2024-02-28
KR20210127955A (ko) 2021-10-25
DK3924361T3 (da) 2023-11-13
AU2020222299B2 (en) 2024-02-08
FI3924361T3 (fi) 2023-12-11
HRP20231582T1 (hr) 2024-03-15
EP3924361A1 (en) 2021-12-22
EP3924361B1 (en) 2023-09-06
EA202192111A1 (ru) 2022-01-26
AU2020222299A1 (en) 2021-10-07
ZA202106037B (en) 2022-05-25
CN113727989B (zh) 2024-02-13
US20220177439A1 (en) 2022-06-09
ES2965305T3 (es) 2024-04-12
PT3924361T (pt) 2023-12-12
BR112021015762A2 (pt) 2021-10-05

Similar Documents

Publication Publication Date Title
IL268282B (en) hiv inhibitory compounds
IL273842A (en) 1-Benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as HIV protease inhibitors
EP3285582A4 (en) Phosphate-substituted quinolizine derivatives useful as hiv integrase inhibitors
EP3377066A4 (en) AMIDOSUBSTITUTED PYRIDOTRIAZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS
EP3377065A4 (en) SPIROCYCLIC PYRIDOTRIAZINE DERIVATIVES USEFUL AS INHIBITORS OF HIV INTEGRASE
ZA202204675B (en) New methylquinazolinone derivatives
GB201916960D0 (en) Compositions
IL289197A (en) History of 2-hydroxycycloalkane-1-carbamoyl
EP3548031A4 (en) TETRACYCLIC HETEROCYCLENE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
SG11202108266PA (en) Compositions
EP4017317A4 (en) EXTENDING TABLE
EP3277755A4 (en) Algae-blended compositions without plasticizers
EP4043450A4 (en) 2H-BENZOPYRAN DERIVATIVES USABLE AS CRAC INHIBITORS
IL289125A (en) the vehicles
EP4017316A4 (en) EXTENDABLE TABLE
EP3573984A4 (en) USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS
IL290815A (en) History of alpha-d-galactopyranoside
IL290964A (en) A 2-aminoquinazolinone derivative
GB201908396D0 (en) Compositions
ZA202209130B (en) Novel triterpene derivatives as hiv inhibitors
ZA202106037B (en) Novel triterpene derivatives as hiv inhibitors
EP3848365A4 (en) TRK INHIBITORS AS AN ANTI-CANCER AGENT
IL285046A (en) Anti-apicomplexan compounds
EP3796900A4 (en) TRITERPENE AMINE DERIVATIVES
GB201919234D0 (en) Compositions